Over the past week, 2,947 new published papers and preprints were released mentioning “covid-19 OR sars-cov-2 OR 2019-nCoV”. This represents 12% of the 25101 written since the outbreak began. A synopsis becomes difficult…
- COVID-19 diagnostics
- Asymptomatic SARS-CoV-2
- Lockdowns in Europe saved millions of lives
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients - A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- Olfactory transmucosal SARS-CoV-2 invasion
- Detection dogs
- Between Scylla and Charybdis with Oncologic Decision making
- Drug Evaluation during the Covid-19 Pandemic
- National COVID numbers-Benford’s law looks for errors
- False Negative Tests
- Waiting for Certainty on Covid-19 Antibody Tests
- Sustaining Rural Hospitals After COVID-19
- Cartography of opportunistic pathogens and antibiotic resistance genes in a tertiary hospital environment
- Surgisphere: mass audit of papers linked to firm behind hydroxychloroquine Lancet study scandal
RENAL
ELSEWHERE
DON’T FORGET TO CLICK ON
Published on Linkedin<https://www.linkedin.com/pulse/covid-snp-11-juin-michel-tsimaratos>
All docs and letters available on-line<https://www.snephroped.org/covid/>
Merci à Philippe Hugot, Martin Christian, Eric Thervet, Alexandre Fabre, Stephane Burtey, Rob Ross Russel, Pierre Cochat, Labros Stefas, Nathalie Quiles et Lucas Percheron.